Skip to content
INTERNATIONAL · DAILY NEWS & INTELLIGENCEAbout
Frankly NewsIndependent Global News & Real-time Analysis.
EditionInternational
HomeHealth

Health01

A study of 30,000 people reveals which antidepressants may work best

A major review involving more than 30,000 people has found that three antidepressants, including Lexapro and Cymbalta, may be more effective than Prozac at...

01HealthFN
Editorial illustration, not a photo of the event.

A major review involving more than 30,000 people has found that three antidepressants, including Lexapro and Cymbalta, may be more effective than Prozac at maintaining improvements in depression symptoms. The study, published in a leading medical journal, analyzed data from dozens of clinical trials comparing commonly prescribed drugs for the treatment of major depressive disorder. Researchers assessed how well each medication sustained symptom relief over time, finding that Lexapro, Cymbalta and a third drug outperformed Prozac in preventing relapse among patients who had initially responded to treatment. The findings offer potentially useful guidance for clinicians weighing treatment options.

However, the authors caution that limitations in the underlying research and a lack of truly long-term data mean scientists still cannot say which antidepressant is best. Most trials followed patients for only a relatively short period, and differences in study design, dosing and patient populations complicate direct comparisons between drugs. The review also did not account for individual factors such as side effects, cost or patient preference, which heavily influence prescribing decisions. Experts not involved in the work said the results should not prompt patients to change medications without consulting their doctors, and stressed that larger, longer trials are needed before firm conclusions can be drawn.

Independent reporting synthesized from primary wires and global correspondents.